跳至主要内容
临床试验/TCTR20200305006
TCTR20200305006招募中未知

Reliability and Validity of Mini-Balance Evaluation System Test (Mini-BESTest) in Type II Diabetic Patients with Peripheral Neuropathy

/A0 个研究点目标入组 36 人开始时间: 2020年3月5日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
36

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
40 Years 至 70 Years(—)
性别
All

入选标准

  • 1) Patients aged between 40 †70 years and both sexes
  • 2) Diagnosis as type 2 diabetes with well-controlled blood glucose based on follow up three times of medical assessments according to medical records
  • 3) Screened with Michigan Neuropathy Screening Instrument (MNSI) and have a MNSI score ≥ 2.5 out of 10 by the researcher (Herman et al. 2012)
  • 4) Diabetic duration of more than 5 years according to the medical record
  • 5) Able to understand the instructions by mini-mental state examination (MMSE) (Roman de Mettelinge et al., 2013)

排除标准

  • 1) Diagnosis as peripheral venous insufficiency, cardiac, renal or hepatic insufficiency, uncontrolled hypertension or myopathic by medical record
  • 2) Diagnosis as central nervous system dysfunction (such as stroke, Parkinson’s disease, and cerebral ataxia) by medical record
  • 3) Foot ulcers by physical examination
  • 4) Fracture of the lower limbs within the 6 months before the study by physical examination
  • 5) Partial or complete blindness by physical examination
  • 6) Severe auditory problems by physical examination (Chatchawan, Eungpinichpong, Plandee, & Yamauchi, 2015) (Marques et al. 2017)

研究者

发起方
/A

相似试验